Home AstraZeneca cancer pipeline seen as draw for Pfizer
 

Keywords :   


AstraZeneca cancer pipeline seen as draw for Pfizer

2014-04-21 14:25:41| Biotech - Topix.net

Pfizer may come back to bid for British drug company AstraZeneca after its reported 60 billion pound takeover approach was rejected, since a deal could make sense for the U.S. pharmaceuticals giant as it seeks to build up its cancer franchise.

Tags: cancer draw pipeline pfizer

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
25.11
25.11 122
25.11PA YAMAHAag03
25.11
25.11 13
25.11DX Z 50th Anniversary Ver.
25.11 11
25.11CUPRUM LUBIN
More »